Invesco’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-202,080
Closed -$3.63M 4081
2022
Q3
$3.63M Buy
+202,080
New +$3.23M ﹤0.01% 2379
2022
Q1
Sell
-26,342
Closed -$410K 4139
2021
Q4
$410K Buy
+26,342
New +$503K ﹤0.01% 3471
2021
Q3
Sell
-23,690
Closed -$540K 4067
2021
Q2
$540K Buy
23,690
+2,470
+12% +$52K ﹤0.01% 3378
2021
Q1
$437K Buy
+21,220
New +$483K ﹤0.01% 3391
2019
Q2
Sell
-38,633
Closed -$922K 3805
2019
Q1
$922K Buy
+38,633
New +$790K ﹤0.01% 3067

Other funds holding MYOV

Invesco's MYOV Position: Q4 2022 in Review

Invesco sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 202,080 shares — an estimated $3.63M sold.

Invesco first reported a position in MYOV in Q1 2019 and held it in 5 quarters. The position peaked at $3.63M in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Invesco reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Invesco sold 202,080 Myovant Sciences Ltd. shares in Q4 2022, an estimated $3.63M.
  • Invesco first reported a position in Myovant Sciences Ltd. in Q1 2019 and held it in 5 quarters.
  • Invesco's Myovant Sciences Ltd. position peaked at $3.63M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.